We would like to ensure that you are still receiving content that you find useful – please confirm that you would like to continue to receive ILO newsletters.
26 June 2017
Bill C-30 was passed by the Senate on May 11 2017 (for more information see "Bill C-30 ushers in changes to Canadian pharma patent regulations"). Bill C-30 implements the Canada-EU Comprehensive Economic and Trade Agreement. On May 16 2017 the bill received royal assent and became an act. However, apart from certain coordinating amendments, the act will not come into force until there is an order in council. Further, before many provisions come into force, regulations will need to be registered.
For further information on this topic please contact Daphne Lainson at Smart & Biggar/Fetherstonhaugh's Ottawa office by telephone (+1 613 232 2486) or email (email@example.com). Alternatively, contact Nancy Pei at Smart & Biggar/Fetherstonhaugh's Toronto office by telephone (+1 416 593 5514) or email (firstname.lastname@example.org). The Smart & Biggar/Fetherstonhaugh website can be accessed at www.smart-biggar.ca.
The materials contained on this website are for general information purposes only and are subject to the disclaimer.
ILO is a premium online legal update service for major companies and law firms worldwide. In-house corporate counsel and other users of legal services, as well as law firm partners, qualify for a free subscription.